RLRita Luciano

Rita Luciano

*This is an algorithmically generated author record based on publicly available information.

Rita Luciano has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report

    by R. Luciano, A. Fracchiolla, D. Ricci, F. Cota, V. D’andrea, F. Gallini, P. Papacci, E. Mercuri, C. Romagnoli

    Preterm infants are at risk for neurodevelopmental sequelae even in absence of major cerebral lesions. The hypothesis that Human Recombinant Erythropoietin (rEpo) could improve the neurodevelopmental outcome in risk neonates has raised the highest interest in recent years. A group of preterm neonates born at a gestational age ≤ 30 weeks and free from major cerebral lesions or major visual impairment, were included in the study if they had a complete neurologic evaluation for at least 24 months of postmenstrual age. They were assigned to group I in the case they had been treated with rEpo or group II if untreated. The aim was to evaluate whether rEpo, given at the high cumulative doses utilized for hematologic purposes, is able to improve the neurodevelopmental outcome in preterm infants born at a gestational age ≤ 30 weeks. A group of 104 preterm neonates were studied: 59 neonates who received rEpo for 6.9 ± 2.4 weeks at a median cumulative dose of 6300 UI/Kg (6337 ± 2434 UI/Kg), starting at a median age of 4 days and 45 neonates who were born in the period preceding the routine use of rEpo. The neurodevelopmental quotient at 24 month postmenstrual age was assessed utilizing the Griffiths’ Mental Developmental Scales. Our results failed to show any difference in the Developmental Quotient at 24 month. Bronchopulmonary dysplasia, minor intraventricular hemorrhages and blood transfusions were the clinical features significantly related to the Developmental Quotient. Our results do not support the hypothesis that rEpo, administered with the schedule utilized for hematologic purposes, improve the neurodevelopmental outcome of preterm neonates, at least those preterm infants free from major impairments.


  • Open Access

    Iron and late preterm

    by Rita Luciano


  • Neonatal neurological examination of late preterm babies

    by Domenico M. Romeo, Rita Luciano, Mirta Corsello, Daniela Ricci, Claudia Brogna, Antonio Zuppa, Costantino Romagnoli, Eugenio Mercuri


  • Is Growth-Discordance in Twins a Substantial Risk Factor in Adverse Neonatal Outcomes?

    by Simonetta Frezza, Francesca Gallini, Maria Puopolo, Maria P. De Carolis, Vito D'ANdrea, Paola I. Guidone, Rita Luciano, Antonio A. Zuppa, Costantino Romagnoli

    To evaluate whether growth discordance is an independent risk factor in the neonatal outcome of the smaller twin, all medical records of twin pregnancies delivered between 26 and 41 weeks during a 5-year period (January 2004–December 2008) were reviewed. Among the 49 selected twins, weight discordance was 15–20% in 7 infants, 21–30% in 16 infants, 31–40% in 16 infants and > 40% in 10 infants. No significant differences between the four groups were found with regards to obstetric complications and neonatal disease. Occurrence of birthweight below the 10th percentile and rate of admission to the neonatal intensive care unit significantly increased as intra-pair birthweight difference increased (p = .03). The > 40% discordant group had a significantly lower gestational age (p = .03), lower birthweight (p = .007) and a significantly higher mortality rate (4/10 versus 3/39 p = .04) in comparison with the other discordant groups. Multiple logistic regression analysis showed that birthweight was the single independent and consistent factor associated with elevated risks of mortality. For every 250 g increase in birthweight, the risk for mortality decreased by about 84% [RR 0.16(CI 0.00-0.70)]. Gestational age was the most reliable predictor for major neonatal complications. For every 1-week increase in gestational age a significant decreased risk for all outcomes was found. Discordance alone should not be considered as a predictor for adverse neonatal outcome. Neonatal outcome in discordant twins appears to be related to gestational age and birthweight rather than to the degree of discordance.


  • Neonatal outcome in hypertensive disorders of pregnancy

    by Sergio Ferrazzani, Rita Luciano, Serafina Garofalo, Vito D'ANdrea, Sara De Carolis, Maria Pia De Carolis, Valentina Paolucci, Costantino Romagnoli, Alessandro Caruso


  • Visual, motor and perceptual abilities at school age in children with isolated mild antenatal ventricular dilatation

    by Francesca Colitto, Flaviana Bianco, Rita Luciano, Valeria Donvito, Giovanni Baranello, Claudia Brogna, Lucia Masini, Stefano Ciotti, Eugenio Mercuri


  • Neurological examination of preterm infants at term equivalent age

    by Daniela Ricci, Domenico M.M. Romeo, Leena Haataja, Ingrid C. van Haastert, Laura Cesarini, Jonna Maunu, Marika Pane, Francesca Gallini, Rita Luciano, Costantino Romagnoli, et al.


  • Infants Born to Mothers With Anti-SSA/Ro Autoantibodies: Neonatal Outcome and Follow-up

    by Antonio Alberto Zuppa, Annalisa Fracchiolla, Francesco Cota, Francesca Gallini, Immacolata Savarese, Vito D'ANdrea, Rita Luciano, Costantino Romagnoli

    Neonatal lupus syndrome is considered a model of passively acquired autoimmune disease. The first 10 newborns born to mothers with connective tissue disease and positive for anti-SSA/Ro antibodies enrolled in a follow-up program to evaluate the incidence of cardiac, hepatobiliary, hematologic, echoencephalographic, and cutaneous manifestations until 9 months of age are described in this study. No congenital heart block was observed, but only transient rhythm alterations were observed. In all, 1 infant showed typical neonatal lupus syndrome skin lesions at 3 months of age. During the neonatal period, echoencephalographic alterations were found more frequently, whereas at follow-up, hepatic and hematologic alterations were more often observed. In all, 1 baby showed persistent neutropenia. A standard program that enrolls all infants born to mothers with anti-SSA/Ro autoantibodies, who are at risk of developing neonatal lupus syndrome, should also include tests performed some time after birth, as a number of clinical manifestations might appear at a late stage.


  • A severe case of intracranial hemorrhage due to alloimmune thrombocytopenia

    by Francesco Cota, Antonio Alberto Zuppa, Rita Luciano, Francesca Gallini, Immacolata Savarese, Giovanni Alighieri, Claudia Orchi, Costantino Romagnoli

    Alloimmune thrombocytopenia (AIT) is an important cause of intrauterine hemorrhagic lesions that result from platelet-antigen incompatibility between mother and foetus. Foetal platelets are destroyed by cross-reactive maternal antibodies that cross the placenta. The most serious complication of AIT is foetal intracranial bleeding that may eventually result in intrauterine death or severe neurological impairments.


  • Antenatal Post-hemorrhagic Ventriculomegaly: A Prospective Follow-up Study

    by R. Luciano, G. Baranello, L. Masini, D. Ricci, F. Gallini, S. Ciotti, D. Leone, F. Serrao, M. Santis, E. Zecca, et al.

    Objective: The aim of this study was to evaluate the presence and the severity of neurological and cognitive impairment at 2 years of age in 16 infants (9 term born, 7 preterm of mean gestation 33.6 weeks) with cerebral ventriculomegaly of antenatal onset associated with intraventricular haemorrhage. Methods: Ventricular dilatation, with or without associated lesions, was, with one exception, not identified on the antenatal routine scan at approximately 22 weeks but was obvious on the scans performed between weeks 27 and 33. In 8 of the 16 cases there were signs of parenchymal involvement or of abnormalities of the corpus callosum or cerebellum. In all patients the diagnosis of antenatal IVH was confirmed by early neonatal imaging. Outcome was measured using the Hammersmith infant neurological examination and the Griffiths developmental scales at 2 years. Results and Conclusions: At 2 years, 8 infants had normal motor outcome and 8 had cerebral palsy. The presence and severity of cerebral palsy or neurodevelopmental delay was not always related to the magnitude or symmetry of the ventricular dilatation per se. The presence of associated lesions was a negative prognostic marker. The early development of epilepsy was also associated with an abnormal outcome.